L Whiteley, S Padmanabhan, D Hole, C Isles - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—There were 192 deaths in 228 subjects with diabetes and 2,016 deaths in 3,076 subjects
with CHD. The highest mortality was in the group with both diabetes and CHD (100.2 deaths/1,000
person-years in men, 93.6 in women) ... Cited by 8 - Related articles - All 2 versions
- Free from Publisher L Whiteley, S Padmanabhan, D Hole, C Isles - Diabetes Care, 2005 - ncbi.nlm.nih.gov OBJECTIVE: The purpose of our study was to confirm or refute the view that diabetes be regarded as a
coronary heart disease (CHD) risk equivalent and to test for sex differences in mortality. RESEARCH
DESIGN AND METHODS: This was a ... Cited by 58 - Related articles - BL Direct - All 6 versions
M Monteverde, B Novak - alapop.org Page 1. El efecto de la obesidad sobre la longevidad: Un análisis comparado para América Latina y el Caribe
Malena Monteverde Beatriz Novak Mesa 06. Población y Salud Sesión 06.1. II Congreso de la Asociación
Latinoamericana de Población Guadalajara, México, 3 – 5 de Septiembre de 2006 ... Related articles - View as HTML - All 2 versions
SM Barreto, VMA Passos, SKF Almeida, … - … de Salud Pública, 2007 - SciELO Public Health Rev Panam Salud Publica/Pan Am J Public Health 22(4), 2007 ... Sandhi Maria Barreto, 1 Valeria
Maria Azeredo Passos, 1 ... Suzanne Kelly Ferreira Almeida, 1 and Tiago Duarte Assis 1 ...
Objective. To estimate ... Related articles - View as HTML - BL Direct - All 12 versions
KB Doshi, SR Kashyap, DM Brennan, BM … - Diabetes, Obesity & …, 2009 - nursing2008.com Aim: It is unclear if metabolic syndrome (MS) is equal to type 2 diabetes mellitus (DM) in
predicting cardiovascular disease (CVD) risk and mortality, and its prognostic value compared to
Framingham risk model is ... Related articles - Cached - All 5 versions
C Rosak, G Mertes - Current Diabetes Reviews, 2009 - ingentaconnect.com Abstract: The alpha-glucosidase inhibitor acarbose is administered to control blood glucose levels
in type 2 diabetic pa- tients and, in several countries, in those with impaired glucose tolerance.
The efficacy and safety of the drug ... Related articles - All 2 versions
[CITATION] The Use of Acarbose as Combination Therapy for Type 2 Diabetics
- ►diabetesjournals.org EJ Boyko - Diabetes care, 2005 - Am Diabetes Assoc Further issues make use of death certificates to assess cause of mortality problematic. Recording of
diabetes is likely to be inconsistent due to the lack of a standardized method for death certificate
coding. Contrast this situation ... Cited by 1 - Related articles - BL Direct - All 5 versions
- ►adisonline.com [PDF] GTC Ko, CC Tsang, CW Ng, HPS Wai, … - Clinical Drug …, 2001 - ingentaconnect.com Gary TC Ko, 1 Chiu-Chi Tsang, 1 Chi-Wai Ng, 1 Hendena PS Wai 2 and Eva CY Kan 1 ... 1 Department of
Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong 2 Department of Clinical Oncology, Pamela
Youde Nethersole Eastern Hospital, ... Cited by 1 - Related articles - BL Direct - All 3 versions
AN Morritt, J Hall - BMJ Career Focus, 2004 - BMJ The death certificate provides legal evidence of death. It enables the patient's family to register
the death and make arrangements for disposal of the body. Mortality statistics derived from death
certification data are vital for ... Cited by 1 - Related articles
